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 INTRODUCTION
IgA nephropathy (IgAN) is the most common cause 
of primary glomerulonephritis (GN) worldwide and a 
major cause of CKD and renal failure. Clinical presenta-
tion is varied but asymptomatic haematuria with pro-
gressive kidney disease is the most frequent manifesta-
tion1. Nephrotic syndrome is rare but has long been 
associated with IgAN2. Although proteinuria is as an 
independent predictor of unfavorable renal outcome3, 
patients with nephrotic syndrome in IgA seem to have 
a different outcome. Recent evidence have shown that 
mild IgAN (M0/1 E0 S0 T0 – C0 Oxford Classification) 
with diffuse foot process effacement on electron 
microscopy (EM) corresponds to IgAN with superim-
posed minimal change disease (MCD) and that these 
patients have remarkably good prognosis with steroid 
therapy4,5. We hereby report a case of IgAN presenting 
with nephrotic syndrome.
 CASE REPORT
19 -year -old male, complaining of strep throat, pre-
scribed Clarithromycin. Two days later he developed gen-
eralized oedema. After one week he presented to the ER 
with hypertension (141/98mmHg) and anasarca. No signs 
of inflamed throat. Chest XR showed bilateral pleural effu-
sion. Laboratory tests showed haemoglobin levels of 
15.2g/dl, 8000 leucocytes count and 214000 platelets. 
Serum creatinine was 0.84mg/dl with eGFR 127ml/min/
m2; with hypoproteinaemia (3,8g/dl); and hypoalbumi-
naemia (1.9g/dl); total cholesterol 419mg/dl; LDL 327mg/
dl. Liver function, serum protein electrophoresis, and 
complement were normal; ANAs, ANCAs, ASOT and viral 
serologies negatives. Urine dipstick with proteinuria 4+, 
haematuria 1+; urinary protein/creatinine ratio was 
9267mg/g and urinary albumin/creatinine ratio 8442mg/g.
A renal biopsy was performed. A total of 13 glomeruli 
were observed, all normal in size, showing mild podocyte 
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hypertrophy, but otherwise unremarkable (Figure 1 and 
2). Tubular epithelium had protein reabsorption droplets. 
Interstitium and vessels were normal. Immunofluores-
cence showed granular mesangial IgA deposits (++) (Fig-
ure 3), C3 (+), Kappa (+) and Lambda (++). Electron micros-
copy showed mesangial deposits and diffuse foot process 
effacement (Figure 4). A IgAN (M0 E0 S0 T0 – C0) was 
diagnosed with superimposed minimal change disease.
Prednisone (60mg q.d.) was started with fairly fast 
response, decreasing proteinuria, and normalization 
of serum albumin and cholesterol levels. Patient was 
lost to follow -up 2 months after biopsy.
 DISCUSSION
IgAN presentation with nephrotic syndrome is rare 
and usually associated to endocapillary proliferation, 
segmental sclerosis, and crescent formation (Oxford 
classification: M1 E1 S1 T1/2 – C1/2). On the other hand, 
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Figure 1
One of the 13 ‘normal’ glomerulus of the biopsy. Note the absence of 
mesangial and endocapillary hypercelullarity and segmental scleros-
ing lesions. (HE 400x).
 
Figure 3
Segmental mesangial granular deposits of IgA (+++). Not shown 
were also granular deposits of C3 (+), Kappa (+) and Lambda (++).
 
Figure 2
Silver stain shows thin and regular capillary walls and discrete 
podocyte hypertrophy ‘sticking out’ from the capillary wall 
(methenamine PAS 400x).
 
Figure 4
Diffuse foot process effacement over 50% of the capillary surface 
area involved (EM 4000x).
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patients with Nephrotic Syndrome associated with mild 
IgAN (M0/1 E0 S0 T0 – C0) seem to have a better prog-
nosis4. According to Herlitz et al, these patients have a 
dual glomerulopathy with superimposed MCD. A recent 
cohort established a clear clinical -pathological differ-
ence between IgAN -MCD and IgA without MCD5. Almost 
all patients with IgAN -MCD in this cohort (n=247) had 
a complete response to steroids and none progressed 
to ESRD. Although more studies are warranted, it seems 
to be a growing evidence that proteinuria in itself is not 
an independent worse prognostic factor. Only electron 
microscopy (EM) can effectively document diffuse foot 
process effacement and make the diagnosis of super-
imposed MCD in these cases. We recommend perform-
ing EM on all IgAN cases presenting with nephrotic 
syndrome and low Oxford classification as these patients 
have improved prognosis with steroid therapy and 
extremely unlikely progression to ESRD.
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